Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday - 2It's been 20 years since MTV's golden couple split. These producers saw it all unravel.
- 37 Methods for further developing Rest Quality
- 4The Job of a Land Legal counselor in Property Exchanges
- 5Metropolitan Greatness: The 6 Urban areas for Quality Living in 2024
- Is an $85 apple pie worth it? Our Thanksgiving taste test says … maybe.
- ‘Nahariya get ready’: Banner displaying Hezbollah threat mounted in Tehran’s Palestine Square
- Commonsense Ways to work on Your Funds with a Restricted Pay
- Oldest evidence of human fire-making discovered at site in England
- The 10 Most Progressive Logical Disclosures
- Burger King launches 'SpongeBob' menu ahead of film's release. A look at the Bikini Bottom-inspired meal, plus what taste testers are saying.
- Ancient fire discovery marks significant milestone in human history
- The Best Computer games for Multiplayer Fun
- Spotify Wrapped and Apple Music Replay are here: Top songs, albums and artists of 2025
